16 September 2010 -- TranScrip Partners LLP, a pharmaceutical development company providing expert advice and hands-on support to pharmaceutical and biotechnology companies across an extensive range of therapeutic areas, today announces the appointment of Gareth Walters. This latest recruitment is set to further enhance the partnership’s existing regulatory affairs capabilities. Furthermore, the 27 strong organisation is set to unveil two further high level appointments over the course of the next two months.
Gareth Walters is a senior drug development professional with over 20 years experience in regulatory affairs, clinical research and product management. His international experience includes 6 years employment at Roche, rising to Project Leader, Global Regulatory Affairs. Subsequently, Gareth joined the founding management team of Protigm Ltd, a novel drug development company and Roche subsidiary, which subsequently metamorphosed into the stand-alone development services organisation, Fulcrum Pharma.
Recently, Gareth served as Regional Director, Medicines Development, for Europe and the US, at Choice Pharma. In this position, he was responsible for the Medicines Development business and oversaw the design and delivery of clinical, drug safety and regulatory services.
Gareth has a PhD in Cardiovascular Studies from the University of Leeds.
Commenting on the appointment: Dr. Flic Gabbay, the Managing Partner of TranScrip, said: “We are very pleased to have Gareth join our expanding partnership and look forward to utilising his skills and expertise as part of our ongoing expansion strategy. In particular, he brings wide ranging, international experience in multiple therapeutic areas and drug development phases, with a strong emphasis on global regulatory strategy and delivery in the European, US, Far Eastern and Japanese regions.”
About TranScrip Partners
TranScrip is a rapidly growing firm of highly respected pharma industry and academic leaders, able to bring creativity towards fast-tracking and de-risking projects, with maturing expansion plans for Europe and the world.
Established in October 2008, TranScrip Partners was specifically created to meet the needs of pharmaceutical companies forced to reduce head counts and consequent access to in-house drug development expertise. TranScrip is structured to fill this gap in the market and can provide pharmaceutical and life science companies with the expertise they require in a wide range of sub-disciplines and therapeutic areas, on both a short and long term basis, drawn from its extensive group of Partners.
Collectively, TranScrip provides knowledge and operational capability in drug development in its widest context, working across multiple therapeutic and ‘functional’ areas. Already substantial by consulting group standards in the pharma space, it offers a flexible model that allows Clients to access Partners’ capabilities to fill skill, experience and/or resource gaps, by integrating with and augmenting Client teams.
TranScrip Partners can provide specific individual experts or layered teams of experienced professionals, which can then evolve as required or as Client objectives change. It offers Clients the support of ‘doers’ who can think strategically and ‘thinkers’ who are happy to get their hands dirty.
Every Client project has leadership and oversight by the most appropriately experienced Partner to ensure “Best in Industry” standards, with built-in continuous professional development for all Partners that interims find hard to afford.
TranScrip Partners can provide:
• Multiple inputs from a variety of TranScrip staff for short, defined projects as well as long-term complex issues
• The full, integrated drug development knowledge of TranScrip Partners with an evolving mix of team members to ensure continuity of support across programme lifetimes
Website: www.transcrip-partners.com
For more information contact:
Tristan Jervis De Facto +44 207 861 3019
Email: t.jervis@defacto.com
Paul Branthwaite TranScrip Partners +44 (0) 118 963 7846 E-mail: paul.branthwaite@transcrip-partners.com
